133 related articles for article (PubMed ID: 33313700)
1. Novel t(1;8)(p31.3;q21.3) NFIA-RUNX1T1 Translocation in an Infant Erythroblastic Sarcoma.
King RL; Siaghani PJ; Wong K; Edlefsen K; Shane L; Howard MT; Reichard KK; Mai M; Viswanatha DS; Greipp PT; Goble TA; Ruiz M; Hara H
Am J Clin Pathol; 2021 Jun; 156(1):129-138. PubMed ID: 33313700
[TBL] [Abstract][Full Text] [Related]
2. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
[TBL] [Abstract][Full Text] [Related]
3. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24).
Micci F; Thorsen J; Panagopoulos I; Nyquist KB; Zeller B; Tierens A; Heim S
Leukemia; 2013 Apr; 27(4):980-2. PubMed ID: 23032695
[No Abstract] [Full Text] [Related]
4.
Liu H; Guinipero TL; Schieffer KM; Carter C; Colace S; Leonard JR; Orr BA; Kahwash SB; Brennan PJ; Fitch JR; Kelly B; Magrini VJ; White P; Wilson RK; Mardis ER; Cottrell CE; Boué DR
Haematologica; 2020 Apr; 105(4):e194-e197. PubMed ID: 31949013
[No Abstract] [Full Text] [Related]
5. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53.
Piqué-Borràs MR; Jevtic Z; Bagger FO; Seguin J; Sivalingam R; Bezerra MF; Louwagie A; Juge S; Nellas I; Ivanek R; Tzankov A; Moll UM; Cantillo O; Schulz-Heddergott R; Fagnan A; Mercher T; Schwaller J
Blood; 2023 May; 141(18):2245-2260. PubMed ID: 36735909
[TBL] [Abstract][Full Text] [Related]
6. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: A rare but distinct clinicopathologic entity.
Linnik Y; Pastakia D; Dryden I; Head DR; Mason EF
Am J Hematol; 2020 Nov; 95(11):E299-E301. PubMed ID: 32697373
[No Abstract] [Full Text] [Related]
8. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
[TBL] [Abstract][Full Text] [Related]
9. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
Abe A; Yamamoto Y; Katsumi A; Okamoto A; Tokuda M; Inaguma Y; Yamamoto K; Yanada M; Kanie T; Tomita A; Akatsuka Y; Okamoto M; Kameyama T; Mayeda A; Emi N
Int J Hematol; 2018 Aug; 108(2):208-212. PubMed ID: 29264741
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
12. Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.
Li H; Hasserjian RP; Kroft SH; Harrington AM; Wheaton SE; Pildain A; Ewalt MD; Gratzinger D; Hosking P; Olteanu H
Am J Clin Pathol; 2016 Apr; 145(4):538-51. PubMed ID: 27124944
[TBL] [Abstract][Full Text] [Related]
13. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
14. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
[TBL] [Abstract][Full Text] [Related]
15. Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant.
Lapadat R; Tower RL; Tam W; Orazi A; Gheorghe G
Pediatr Blood Cancer; 2016 May; 63(5):935-7. PubMed ID: 26773805
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia].
Gao HT; Zhang Y; Sun K; Guo JM; Chen YQ; Chen XL; Shi J; Niu XN; Wang F; Huo L
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):210-215. PubMed ID: 28395444
[No Abstract] [Full Text] [Related]
18. Pediatric acute erythroid leukemias with monocytic antigen expression and novel chromosomal translocations.
Zhu GG; Inam Z; Calleroz A; Pillai V; Schore RJ; Cheng J
Pediatr Blood Cancer; 2023 Aug; 70(8):e30333. PubMed ID: 37073602
[No Abstract] [Full Text] [Related]
19. Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia.
Micci F; Thorsen J; Haugom L; Zeller B; Tierens A; Heim S
Leukemia; 2011 Sep; 25(9):1510-2. PubMed ID: 21606959
[No Abstract] [Full Text] [Related]
20. A new NFIA:RAF1 fusion activating the MAPK pathway in pilocytic astrocytoma.
Yde CW; Sehested A; Mateu-Regué À; Østrup O; Scheie D; Nysom K; Nielsen FC; Rossing M
Cancer Genet; 2016 Oct; 209(10):440-444. PubMed ID: 27810072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
